Catheter

At 5 years, patients with atrial fibrillation assigned catheter ablation had reduced recurrence of any AF compared with those assigned drug therapy, according to new data from the CABANA trial.

Boston Scientific announced the launch of a monitoring tool to assess effects of radiofrequency energy delivery during cardiac ablation procedures.

Healio and Cardiology Today have compiled a list of the top news from the virtual Heart Rhythm Society Annual Scientific Sessions.

Radiofrequency ablation with a heated saline needle catheter was effective in eliminating clinical ventricular tachycardia in patients who did not respond to prior treatments, according to data from the SERF study presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

The FDA has designated Applied Medical’s recall of three latex balloon catheters as a class 1 recall, the most serious kind.

Study findings indicated that although most patients who had insurance before developing end-stage renal disease initiate hemodialysis with a central venous catheter, use of fistula for vascular access demonstrated the lowest risk for subsequent bloodstream infections.

Ablation with a porous tip contact force-sensing catheter was safe and effective in patients with persistent atrial fibrillation, according to data from the PRECEPT study presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

The FDA has designated Boston Scientific’s recall of angiographic catheters used for contrast agent delivery as a class 1 recall, the most serious kind.

The FDA has identified the recall of LeMaitre Vascular’s balloon embolectomy catheter as class 1, the most serious kind, due to risk for death or injury from balloon deflation failure.

Catheter-based renal denervation was superior to a sham procedure for reducing BP in the absence of antihypertensive medications in patients with uncontrolled hypertension, according to results of the SPYRAL HTN-OFF MED pivotal trial.